FHTX
Foghorn Therapeutics Inc
2.00$
+0.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.8% | -10.8% | +28.9% | -6.2% | -7.9% | -8.9% | -12.5% | -9.4% | -3.3% | +12.1% | -8.5% | |
| – | -9.5% | -11.9% | +36.9% | -6.3% | -8.0% | -9.7% | -9.6% | -9.7% | -11.3% | +15.2% | -9.6% | |
| – | +14.3% | -1.3% | +75.3% | -58.5% | -3.9% | +10.0% | +18.9% | +23.1% | -9.5% | +9.9% | -23.4% | |
| – | -9.9% | -11.7% | +38.0% | -6.2% | -8.8% | -9.5% | -9.9% | -9.3% | -11.9% | +16.4% | -9.4% | |
| – | -2.1% | -2.9% | -2.7% | -1.8% | -2.1% | -2.8% | -5.4% | -2.7% | +4.1% | -2.6% | -4.7% | |
| – | +12.4% | -10.9% | -2.3% | +11.7% | +17.9% | +6.4% | +9.1% | +9.4% | -29.8% | +7.8% | -21.5% | |
| – | +1.7% | +1.8% | -3.4% | +4.7% | +3.4% | +0.5% | -32.2% | +9.4% | -86.3% | +101.8% | +51.3% | |
| – | -3.6% | -10.0% | -14.5% | -28.3% | +9.7% | +7.5% | -18.4% | -3.3% | +32.8% | -22.2% | -3.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.6% | +0.3% | +21.6% | +21.4% | +0.0% | +0.4% | +0.2% | +0.1% | -0.1% | +10.4% | +1.6% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.